# Low Dose Growth Hormone (GH) on Insulin Sensitivity and Cortisol Production Rates

> **NCT00517062** · EARLY_PHASE1 · COMPLETED · sponsor: **Oregon Health and Science University** · enrollment: 16 (actual)

## Conditions studied

- Growth Hormone Deficiency

## Interventions

- **DRUG:** Growth hormone (Genotropin)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00517062
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2012-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00517062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00517062, "Low Dose Growth Hormone (GH) on Insulin Sensitivity and Cortisol Production Rates". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00517062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*